UBS Group’s Neuphoria Therapeutics Inc. Common Stock NEUP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,978
| Closed | -$10.2K | – | 9435 |
|
|
2024
Q4 | $10.2K | Buy |
+2,978
| New | +$10.2K | ﹤0.01% | 7071 |
|
|
2024
Q3 | – | Sell |
-2,908
| Closed | -$26.8K | – | 8904 |
|
|
2024
Q2 | $26.8K | Buy |
2,908
+2,080
| +251% | +$19.1K | ﹤0.01% | 5971 |
|
|
2024
Q1 | $10.2K | Buy |
828
+801
| +2,967% | +$9.9K | ﹤0.01% | 6066 |
|
|
2023
Q4 | $487 | Sell |
27
-180
| -87% | -$3.25K | ﹤0.01% | 7422 |
|
|
2023
Q3 | $6.7K | Buy |
+207
| New | +$6.7K | ﹤0.01% | 6143 |
|
|
2023
Q1 | – | Sell |
-73
| Closed | -$4.05K | – | 9162 |
|
|
2022
Q4 | $4.05K | Buy |
73
+62
| +564% | +$3.44K | ﹤0.01% | 8199 |
|
|
2022
Q3 | $1K | Buy |
11
+6
| +120% | +$545 | ﹤0.01% | 8957 |
|
|
2022
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 9842 |
|
|
2022
Q1 | $0 | Sell |
5
-81
| -94% | – | ﹤0.01% | 9705 |
|
|
2021
Q4 | $13K | Buy |
+86
| New | +$13K | ﹤0.01% | 7357 |
|